Navigation Links
Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors

NEW YORK, Nov. 12 /PRNewswire/ -- Informed Medical Communications (IMC), one of the nation's premier interactive medical information service companies, today named Charles T. Saldarini to its Board of Directors. The announcement was issued by IMC CEO, Steven K. Budd, from the company's headquarters in New York City.

Mr. Saldarini brings to IMC an extensive history of entrepreneurial innovation in the area of healthcare services, most recently as a driving force behind New Jersey-based PDI, Inc., a leading provider of outsourced sales and marketing solutions to the biopharmaceutical industry. During his 18-year tenure with the company, Mr. Saldarini played a central role in establishing PDI as one of the healthcare industry's most respected service companies.

Speaking on behalf of IMC, Mr. Budd said "we are thrilled to be gaining the insights and experience of such an accomplished and well-respected executive." The CEO added that today's appointment coincides with a recent expansion of IMC's client base and a renewed focus on growing the company's service lines. "The timing is excellent," Mr. Budd noted, "for us to benefit from Chuck's experience in aggressively executing business plans while delivering meaningful innovation to clients."

Mr. Saldarini pointed to the stellar reputation of IMC's two main divisions, The Peer Group and HealthTalk, and said that he was looking forward to working with Mr. Budd once again and to helping guide IMC through its next phase of development. "I have worked closely with Steve for many years," Saldarini said, "and have the utmost confidence in his abilities to deliver great value to both clients and shareholders."

About Informed Medical Communications

Informed Medical Communications (, headquartered in New York City, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include: The Peer Group, an industry innovator and leader in conducting peer-to-peer medical programs; HealthTalk, a pioneer in providing disease information and support resources that empower patients and caregivers coping with serious medical conditions to proactively and effectively manage their diseases; RxDialogue, a consumer relationship marketing company designed to give patients a deeper understanding of benefits and risks of treatment options in a highly personalized format not provided in traditional advertising; and MRxHealth, a market research and consulting firm that provides insights into the development and effectiveness of non-traditional marketing programs for physicians and patients. The IMC network of companies delivers integrated marketing programs for patients, physicians, medical professionals and payors, with the goal of improving the dialogue among patients and physicians in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.

Contact: Patrick Aysseh, Informed Medical Communications, (646) 358-1304, patricka [at] informedmedical [dot] com

SOURCE Informed Medical Communications
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):